225
Participants
Start Date
October 31, 1999
Primary Completion Date
November 30, 2003
Study Completion Date
December 31, 2005
Dexamethasone / Prednisolone
Cyclophosphamide
Methotrexate
Vincristine / Vindesine
Daunorubicin
Asparaginase
G-CSF
Cytarabine
6-Mercaptopurine
VP16
Adriamycin
Thioguanine
VM26
Idarubicin
Fludarabine
Ifosfamide
CNS irradiation
Mediastinal irradiation (if residual tumor)
stem cell transplantation
University Hospital, Medical Dept. II, Frankfurt
Lead Sponsor
Goethe University
OTHER